NATIONAL BUREAU OF ECONOMIC RESEARCH
NATIONAL BUREAU OF ECONOMIC RESEARCH

Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process

Ernst R. Berndt, Adrian H. B. Gottschalk, Tomas Philipson

Chapter in NBER book Frontiers in Health Policy Research, Volume 8 (2005), David M. Cutler and Alan M. Garber *
Published in June 2005

This chapter first appeared as NBER working paper w10822, Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process, Ernst R. Berndt, Adrian H. B. Gottschalk, Tomas Philipson, Matthew W. Strobeck

This paper is not currently available on-line.
(The online version is in preparation and may be available in a few days).

Machine-readable bibliographic record - MARC, RIS, BibTeX

 
Publications
Activities
Meetings
Data
People
About

National Bureau of Economic Research, 1050 Massachusetts Ave., Cambridge, MA 02138; 617-868-3900; email: info@nber.org